These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 36514405)

  • 1. SARS-CoV-2 Infections among Vaccinated Patients on Maintenance Dialysis, January 1-August 31, 2021, United States.
    Bardossy AC; Angeles J; Booth S; Fike L; Wadley A; Rha B; Lacson E; Manley HJ; Johnson D; Apata IW; Novosad S
    Kidney360; 2022 Nov; 3(11):1934-1938. PubMed ID: 36514405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
    Navarrete J; Barone G; Qureshi I; Woods A; Barbre K; Meng L; Novosad S; Li Q; Soe MM; Edwards J; Wong E; Reses HE; Guthrie S; Keenan J; Lamping L; Park M; Dumbuya S; Benin AL; Bell J
    MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(32):871-876. PubMed ID: 37561674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.
    Hsu CM; Weiner DE; Aweh G; Miskulin DC; Manley HJ; Stewart C; Ladik V; Hosford J; Lacson EC; Johnson DS; Lacson E
    Am J Kidney Dis; 2021 May; 77(5):748-756.e1. PubMed ID: 33465417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Reported Deaths Among Fully Vaccinated Persons With Coronavirus Disease 2019-United States, January-April 2021.
    François Watkins LK; Mitruka K; Dorough L; Bressler SS; Kugeler KJ; Sadigh KS; Birhane MG; Nolen LD; Fischer M
    Clin Infect Dis; 2022 Aug; 75(1):e645-e652. PubMed ID: 35092677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021.
    Kugeler KJ; Williamson J; Curns AT; Healy JM; Nolen LD; Clark TA; Martin SW; Fischer M
    PLoS One; 2022; 17(3):e0264179. PubMed ID: 35263352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
    Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
    Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths.
    Mor V; Gutman R; Yang X; White EM; McConeghy KW; Feifer RA; Blackman CR; Kosar CM; Bardenheier BH; Gravenstein SA
    J Am Geriatr Soc; 2021 Aug; 69(8):2063-2069. PubMed ID: 33861873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.
    McGovern OL; Stenger M; Oliver SE; Anderson TC; Isenhour C; Mauldin MR; Williams N; Griggs E; Bogere T; Edens C; Curns AT; Lively JY; Zhou Y; Xu S; Diaz MH; Waller JL; Clarke KR; Evans ME; Hesse EM; Morris SB; McClung RP; Cooley LA; Logan N; Boyd AT; Taylor AW; Bajema KL; Lindstrom S; Elkins CA; Jones C; Hall AJ; Graitcer S; Oster AM; Fry AM; Fischer M; Conklin L; Gokhale RH
    PLoS One; 2021; 16(4):e0249901. PubMed ID: 33857209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response to vaccination against SARS-CoV-2 in patients undergoing dialysis.
    Lee YJ; Park BS; Heo CM; Park S; Yu S; Kim YW
    Medicine (Baltimore); 2022 Dec; 101(50):e32152. PubMed ID: 36550899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding Ways to Reduce Coronavirus Exposure During Dialysis.
    Rubin R
    JAMA; 2020 May; 323(20):1993-1995. PubMed ID: 32297904
    [No Abstract]   [Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Seasonal Influenza Vaccination among Dialysis Facilities in the United States.
    Danziger J; Weinhandl E; Friedman D; Mukamal KJ
    J Am Soc Nephrol; 2020 Sep; 31(9):2117-2121. PubMed ID: 32817310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated.
    Weinhandl ED
    Curr Opin Nephrol Hypertens; 2022 Mar; 31(2):185-190. PubMed ID: 35086986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil.
    Gorayeb-Polacchini FS; Caldas HC; Bottazzo AC; Abbud-Filho M
    Braz J Infect Dis; 2021; 25(3):101595. PubMed ID: 34273270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States.
    Dawood FS; Varner M; Tita A; Newes-Adeyi G; Gyamfi-Bannerman C; Battarbee A; Bruno A; Daugherty M; Reichle L; Vorwaller K; Vargas C; Parks M; Powers E; Lucca-Susana M; Gibson M; Subramaniam A; Cheng YJ; Feng PJ; Ellington S; Galang RR; Meece J; Flygare C; Stockwell MS
    Clin Infect Dis; 2022 Jul; 74(12):2218-2226. PubMed ID: 34410340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience.
    Strickler SS; Esper A; Wells L; Wood A; Frediani JK; Nehl E; Waggoner JJ; Rebolledo PA; Levy JM; Figueroa J; Ramachandra T; Lam W; Martin GS
    Front Med (Lausanne); 2022; 9():1031083. PubMed ID: 36507539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.